: BIONTECH SAYS DATA INDICATE THAT THE VACCINE IS STILL EFFECTIVE IN PREVENTING COVID-19, ALSO AGAINST OMICRON, IF IT HAS BEEN ADMINISTERED THREE TIMES
: PFIZER INC - DATA INDICATE THAT THIRD DOSE OF BNT162B2 INCREASES NEUTRALIZING ANTIBODY TITERS BY 25-FOLD COMPARED TO TWO DOSES AGAINST OMICRON VARIANT
: PFIZER INC - HAVE HIGH CONFIDENCE THAT IF NEEDED THEY CAN DELIVER AN OMICRON-BASED VACCINE IN MARCH 2022
Yorum:
OPTIMISM
Weakness JPY, weakness gold, strength equities
Yorum:
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.
: PFIZER INC - DATA INDICATE THAT THIRD DOSE OF BNT162B2 INCREASES NEUTRALIZING ANTIBODY TITERS BY 25-FOLD COMPARED TO TWO DOSES AGAINST OMICRON VARIANT
: PFIZER INC - HAVE HIGH CONFIDENCE THAT IF NEEDED THEY CAN DELIVER AN OMICRON-BASED VACCINE IN MARCH 2022